Seegene Completes IPO, Raises $16.6M | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Korean molecular diagnostics firm Seegene today said it has raised $16.6 million in its initial public offering.

The company said it had sold 636,500 shares of its stock on the KOSDAQ (Korea Securities Dealers Automated Quotations) at KRW30,500 ($26.16) per share, and now has a market capitalization of $167 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.